CR11144A - Disolucion directa del docetaxel en un disolvente en polisorbato 80 - Google Patents

Disolucion directa del docetaxel en un disolvente en polisorbato 80

Info

Publication number
CR11144A
CR11144A CR11144A CR11144A CR11144A CR 11144 A CR11144 A CR 11144A CR 11144 A CR11144 A CR 11144A CR 11144 A CR11144 A CR 11144A CR 11144 A CR11144 A CR 11144A
Authority
CR
Costa Rica
Prior art keywords
solvent
docetaxel
polisorbate
direct dissolution
dissolution
Prior art date
Application number
CR11144A
Other languages
English (en)
Inventor
Jean-Rene Authelin
Eric Didier
Elie Fouque
Mostafa Nakach
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39048780&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR11144(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of CR11144A publication Critical patent/CR11144A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invencion se refiere a la solubilizacion del docetaxel en un disolvente organico, a su mezcla con polisorbato 80 y a la evaporacion del disolvente.
CR11144A 2007-06-08 2009-12-03 Disolucion directa del docetaxel en un disolvente en polisorbato 80 CR11144A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0704095A FR2917088B1 (fr) 2007-06-08 2007-06-08 Dissolution directe du docetaxel dans un solvant dans le polysorbate 80

Publications (1)

Publication Number Publication Date
CR11144A true CR11144A (es) 2010-03-23

Family

ID=39048780

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11144A CR11144A (es) 2007-06-08 2009-12-03 Disolucion directa del docetaxel en un disolvente en polisorbato 80

Country Status (32)

Country Link
US (1) US20100197776A1 (es)
EP (1) EP2155189A2 (es)
JP (1) JP2010529094A (es)
KR (1) KR20100022033A (es)
CN (2) CN102908309A (es)
AR (1) AR066889A1 (es)
AU (1) AU2008270141A1 (es)
BR (1) BRPI0812438A2 (es)
CA (1) CA2689466A1 (es)
CL (1) CL2008001650A1 (es)
CO (1) CO6260063A2 (es)
CR (1) CR11144A (es)
DO (1) DOP2009000249A (es)
EA (1) EA200971137A1 (es)
EC (1) ECSP099789A (es)
FR (1) FR2917088B1 (es)
GT (1) GT200900306A (es)
HN (1) HN2009003363A (es)
IL (1) IL202517A0 (es)
MA (1) MA31671B1 (es)
MX (1) MX2009013216A (es)
MY (1) MY151417A (es)
NI (1) NI200900209A (es)
NZ (1) NZ581634A (es)
PA (1) PA8783101A1 (es)
SV (1) SV2009003428A (es)
TN (1) TN2009000396A1 (es)
TW (1) TW200916095A (es)
UA (1) UA99828C2 (es)
UY (1) UY31129A1 (es)
WO (1) WO2009004188A2 (es)
ZA (1) ZA200908662B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG185389A1 (en) 2010-05-03 2012-12-28 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
US6040330A (en) * 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US20020041898A1 (en) * 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
EP1815869A4 (en) * 2004-11-24 2011-04-06 Nanocarrier Co Ltd PROCESS FOR CHANGING THE MORPHOLOGY OF BLOCK COPOLYMERS
BRPI0600194A (pt) * 2006-01-30 2007-10-23 Quiral Quimica Do Brasil S A composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas

Also Published As

Publication number Publication date
CN102908309A (zh) 2013-02-06
AU2008270141A1 (en) 2009-01-08
UA99828C2 (ru) 2012-10-10
TN2009000396A1 (fr) 2010-12-31
UY31129A1 (es) 2009-01-30
NZ581634A (en) 2012-05-25
EP2155189A2 (fr) 2010-02-24
NI200900209A (es) 2010-10-04
US20100197776A1 (en) 2010-08-05
TW200916095A (en) 2009-04-16
AR066889A1 (es) 2009-09-16
MA31671B1 (fr) 2010-09-01
EA200971137A1 (ru) 2010-04-30
KR20100022033A (ko) 2010-02-26
ZA200908662B (en) 2011-04-28
JP2010529094A (ja) 2010-08-26
CO6260063A2 (es) 2011-03-22
ECSP099789A (es) 2010-01-29
CL2008001650A1 (es) 2009-10-23
CA2689466A1 (fr) 2009-01-08
CN101677986A (zh) 2010-03-24
DOP2009000249A (es) 2009-11-30
MX2009013216A (es) 2010-01-25
IL202517A0 (en) 2010-06-30
GT200900306A (es) 2011-06-17
PA8783101A1 (es) 2009-01-23
WO2009004188A3 (fr) 2009-03-26
FR2917088B1 (fr) 2009-09-04
SV2009003428A (es) 2010-02-05
HN2009003363A (es) 2013-09-18
WO2009004188A2 (fr) 2009-01-08
MY151417A (en) 2014-05-30
FR2917088A1 (fr) 2008-12-12
BRPI0812438A2 (pt) 2014-12-02

Similar Documents

Publication Publication Date Title
CY1121879T1 (el) Συνθεσεις και μεθοδοι για διαμορφωση hbv και ttr εκφρασης
CL2016001757A1 (es) Linterna portátil y luz de escenario.
ATE438697T1 (de) Organische elektrolumineszenzvorrichtungen
TW200740956A (en) Organic electroluminescent devices
CL2007000311A1 (es) Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende;y su uso en el trastamiento de un trastorno proliferativos como es el cancer.
ATE538157T1 (de) Indenofluoren- und thiophen-copolymere
HN2006018410A (es) Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion
BR112017007431A2 (pt) compósitos termoplásticos de fibra longa híbridos
CL2008001268A1 (es) Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor.
GT200600097A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
EA200601759A1 (ru) Композиции рамиприла
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
MX280211B (es) Polimero, un metodo para producir el polimero y una mezcla de cemento que utiliza el mismo.
CL2011000979A1 (es) Compuestos derivados ftalazina 1,4-disustituida; composicion farmaceutica; y su uso en el tratamiento del cancer.
CL2011000268A1 (es) Uso de dronedarona para preparar un medicamento util en la prevencion del ictus o ataque isquemico transitorio.
CR11144A (es) Disolucion directa del docetaxel en un disolvente en polisorbato 80
RU2013132639A (ru) Сопряженный полимер на основе карбазола, бензотиадиазола, бензола и тиофена и его применение в качестве электролюминесцентного материала в органических светоизлучающих диодах
CL2013000210A1 (es) Compuestos derivados de tiofeno 2,3,5 trisustituidos; composición farmacéutica; combinación farmacéutica; y su uso para el tratamiento de un trastorno o enfermedad en un sujeto causado o asociado con una infeccion por vhc, tales como cirrosis hepatica, carcinoma hepatocelular, entre otras.
ECSP12012343A (es) Una combinación antitumoral que comprende ombrabulina, un derivado de taxano y un derivado de platino
BRMU8601079U (pt) bóton para expressar sentimento de luto
CL2012002092A1 (es) Composicion farmaceutica que comprende vx-222 y vx-950; donde vx-950 mejora la farmacocinetica de vx -222; uso en el tratamiento de la hepatitis c.
RU2013139993A (ru) Сопряженный полимер на основе карбазола и циклопентадитиофена и его применение в качестве электролюминесцентного материала в органических светоизлучающих диодах
AR069217A1 (es) Formulacion piojicida
CY1116095T1 (el) Πεπτιδικοι αγωνιστες gla-2
TH1701002334A (th) โครเมนซึ่งถูกแทนที่และวิธีการใช้

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)